Hopes were high for a rebound in capital-markets activity this year A few notable Health Care deals along with M&A in the ...
Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback